Alpana Waghmare
- Infectious Diseases top 5%
- Viral gastroenteritis research and epidemiology 11
- SARS-CoV-2 and COVID-19 Research 10
- COVID-19 Clinical Research Studies 10
- Epidemiology top 5%
- Respiratory viral infections research 43
- Cytomegalovirus and herpesvirus research 9
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation 8
- Oncology top 10%
- Molecular Biology top 10%
-
- Transplantation: Methods and Outcomes 10
- Congenital Diaphragmatic Hernia Studies 6
Alpana Waghmare
61 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Infectious Diseases 497
- Epidemiology 721
- Hematology 207
- Oncology 445
- Molecular Biology 952
Countries citing papers authored by Alpana Waghmare
This map shows the geographic impact of Alpana Waghmare's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpana Waghmare with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpana Waghmare more than expected).
Fields of papers citing papers by Alpana Waghmare
This network shows the impact of papers produced by Alpana Waghmare. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpana Waghmare. The network helps show where Alpana Waghmare may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alpana Waghmare, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 8 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 2 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 6 | |
| 11 | 2022 | 10 | |
| 12 | 2022 | 23 | |
| 13 | 2022 | 11 | |
| 14 | 2020 | 9 | |
| 15 | 2020 | 46 | |
| 16 | 2019 | 1 | |
| 17 | 2018 | 24 | |
| 18 | 2018 | 22 | |
| 19 | 2014 | 34 | |
| 20 | 2013 | 93 |
About Alpana Waghmare
Alpana Waghmare is a scholar working on Epidemiology, Infectious Diseases and Hematology, having authored 65 papers that have together received 2.1k indexed citations. Recurring topics across this work include Respiratory viral infections research (43 papers), Viral gastroenteritis research and epidemiology (11 papers), SARS-CoV-2 and COVID-19 Research (10 papers), COVID-19 Clinical Research Studies (10 papers), Transplantation: Methods and Outcomes (10 papers), Cytomegalovirus and herpesvirus research (9 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Congenital Diaphragmatic Hernia Studies (6 papers). The work is most often cited by research in Infectious Diseases (497 citations), Epidemiology (721 citations) and Hematology (207 citations). Alpana Waghmare has collaborated with scholars based in United States, South Korea and South Africa. Frequent co-authors include Rudolf Jaenisch, François Gaudet, Amir Eden, Janet A. Englund, Michael Boeckh, Jane Kuypers, Keith R. Jerome, Wendy M. Leisenring, Hu Xie and Chikara Ogimi. Their work appears in journals such as Science, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.